Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 235

    1.

    The effects of atorvastatin in experimental autoimmune uveitis.

    Thomas PB, Albini T, Giri RK, See RF, Evans M, Rao NA.

    Br J Ophthalmol. 2005 Mar;89(3):275-9.PMID: 15722302 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

    Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS.

    Nature. 2002 Nov 7;420(6911):78-84.PMID: 12422218 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.

    Liu W, Li WM, Gao C, Sun NL.

    J Autoimmun. 2005 Dec;25(4):258-63. Epub 2005 Oct 19.PMID: 16242301 [PubMed - indexed for MEDLINE]Related articles

    4.

    Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.

    Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M.

    Jpn J Ophthalmol. 2001 Sep-Oct;45(5):463-9.PMID: 11583666 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.

    Kohno H, Sakai T, Saito S, Okano K, Kitahara K.

    Exp Eye Res. 2007 Mar;84(3):569-76. Epub 2007 Jan 17.PMID: 17208229 [PubMed - indexed for MEDLINE]Related articles

    6.

    Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.

    Li WM, Liu W, Gao C, Zhou BG.

    Immunol Cell Biol. 2006 Jun;84(3):274-80.PMID: 16509827 [PubMed - indexed for MEDLINE]Related articles

    7.

    Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.

    Keino H, Watanabe T, Sato Y, Niikura M, Wada Y, Okada AA.

    Arthritis Res Ther. 2008;10(5):R122. Epub 2008 Oct 13.PMID: 18847496 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis.

    Sellner J, Greeve I, Findling O, Kamm CP, Minten C, Engelhardt B, Grandgirard D, Leib SL, Mattle HP.

    Neurochem Int. 2008 Jul;53(1-2):17-21. Epub 2008 Apr 20.PMID: 18524417 [PubMed - indexed for MEDLINE]Related articles

    9.

    The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.

    Wu Y, Wang Y, Zhong C, Li Y, Li X, Sun B.

    Int Immunopharmacol. 2003 Oct;3(10-11):1457-65.PMID: 12946442 [PubMed - indexed for MEDLINE]Related articles

    10.

    Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.

    Kwak HJ, Yang YS, Pae HO, Kim YM, Chung HT.

    Mol Cells. 2001 Oct 31;12(2):178-84.PMID: 11710518 [PubMed - indexed for MEDLINE]Related articles

    11.

    The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis.

    Fukai T, Okada AA, Sakai J, Kezuka T, Keino H, Usui M, Yagita H, Okumura K, Mizuguchi J.

    Graefes Arch Clin Exp Ophthalmol. 1999 Nov;237(11):928-33.PMID: 10541904 [PubMed - indexed for MEDLINE]Related articles

    12.

    Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response.

    Sun B, Rizzo LV, Sun SH, Chan CC, Wiggert B, Wilder RL, Caspi RR.

    J Immunol. 1997 Jul 15;159(2):1004-11.PMID: 9218623 [PubMed - indexed for MEDLINE]Related articles

    13.

    The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.

    Silver PB, Chan CC, Wiggert B, Caspi RR.

    Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2898-905.PMID: 10549650 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.

    Haq E, Rohrer B, Nath N, Crosson CE, Singh I.

    J Ocul Pharmacol Ther. 2007 Jun;23(3):221-31.PMID: 17593005 [PubMed - indexed for MEDLINE]Related articles

    15.

    IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.

    Jiang HR, Wei X, Niedbala W, Lumsden L, Liew FY, Forrester JV.

    Invest Ophthalmol Vis Sci. 2001 Jan;42(1):177-82.PMID: 11133864 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.

    Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR.

    J Immunol. 1997 Jun 15;158(12):5997-6005.PMID: 9190954 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.

    Yokoi H, Kato K, Kezuka T, Sakai J, Usui M, Yagita H, Okumura K.

    Eur J Immunol. 1997 Mar;27(3):641-6.PMID: 9079803 [PubMed - indexed for MEDLINE]Related articles

    19.

    Analysis of cytokine functions in graft rejection by gene expression profiles.

    Liang Y, Christopher K, DeFina R, Cidado J, He H, Haley KJ, Finn PW, Perkins DL.

    Transplantation. 2003 Dec 27;76(12):1749-58.PMID: 14688527 [PubMed - indexed for MEDLINE]Related articles

    20.

    Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

    Dunn SE, Youssef S, Goldstein MJ, Prod'homme T, Weber MS, Zamvil SS, Steinman L.

    J Exp Med. 2006 Feb 20;203(2):401-12. Epub 2006 Feb 13.PMID: 16476765 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data